Marta Mellai

2.3k total citations
57 papers, 1.8k citations indexed

About

Marta Mellai is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Marta Mellai has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Genetics and 11 papers in Oncology. Recurrent topics in Marta Mellai's work include Glioma Diagnosis and Treatment (26 papers), MicroRNA in disease regulation (6 papers) and Epigenetics and DNA Methylation (6 papers). Marta Mellai is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), MicroRNA in disease regulation (6 papers) and Epigenetics and DNA Methylation (6 papers). Marta Mellai collaborates with scholars based in Italy, Belarus and United States. Marta Mellai's co-authors include Davide Schiffer, Laura Annovazzi, Valentina Caldera, Guido Valente, Paola Cassoni, Cristina Casalone, Cristiano Corona, Chiara Riganti, Luigi Battaglia and Mara Giordano and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Marta Mellai

57 papers receiving 1.8k citations

Peers

Marta Mellai

GENET

ONCOL

IMMUN

Laura Annovazzi Italy

Ulf D. Kahlert Germany

Valentina Caldera Italy

Venkata Ramesh Dasari United States

Fan Zeng China

Carsten Hagemann Germany

Nadine Platet France

Mark C. de Gooijer Netherlands

Corinne E. Griguer United States

John L. Darling United Kingdom

Laura Annovazzi Italy

Marta Mellai

782 ×0.9

542 ×0.9

GENET

352 ×0.9

307 ×0.9

ONCOL

188 ×0.8

IMMUN

Citations per year, relative to Marta Mellai Marta Mellai (= 1×) peers Laura Annovazzi

Countries citing papers authored by Marta Mellai

Since Specialization

Citations

This map shows the geographic impact of Marta Mellai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Mellai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Mellai more than expected).

Fields of papers citing papers by Marta Mellai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Mellai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Mellai. The network helps show where Marta Mellai may publish in the future.

Co-authorship network of co-authors of Marta Mellai

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Mellai. A scholar is included among the top collaborators of Marta Mellai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Mellai. Marta Mellai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sculco, Marika, G. Sala, Elettra Barberis, et al.. (2025). Gut microbiota and metabolome signatures in obese and normal-weight patients with colorectal tumors. iScience. 28(4). 112221–112221. 1 indexed citations

Mellai, Marta, et al.. (2024). A Randomized, Double-Blind, Placebo-Controlled Trial: Efficacy of Opuntia ficus-indica Prebiotic Supplementation in Subjects with Gut Dysbiosis. Nutrients. 16(5). 586–586. 5 indexed citations

Favero, Francesco, Angela Re, Mara Gagliardi, et al.. (2024). Characterization of gut microbiota dynamics in an Alzheimer’s disease mouse model through clade-specific marker-based analysis of shotgun metagenomic data. Biology Direct. 19(1). 100–100. 3 indexed citations

Bianco, Salvatore Lo, et al.. (2024). Pilot, open-label, randomized controlled clinical trial evaluating 4 oral hygiene regimens using a manual toothbrush, toothpaste, and mouthwash.. PubMed. 72(4). 62–71. 1 indexed citations

Mellai, Marta, et al.. (2022). Influence of Sex on the Microbiota of the Human Face. Microorganisms. 10(12). 2470–2470. 18 indexed citations

Mellai, Marta, Laura Annovazzi, Renzo Boldorini, et al.. (2019). SEL1L plays a major role in human malignant gliomas. The Journal of Pathology Clinical Research. 6(1). 17–29. 8 indexed citations

Salaroglio, Iris C., Carmen Abate, Barbara Rolando, et al.. (2019). Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain–Blood Barrier and Glioblastoma Stem Cells. Molecular Pharmaceutics. 16(8). 3361–3373. 21 indexed citations

Salaroglio, Iris C., Prashant Mujumdar, Laura Annovazzi, et al.. (2018). Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein–Mediated Resistance to Temozolomide in Glioblastoma. Molecular Cancer Therapeutics. 17(12). 2598–2609. 36 indexed citations

Schiffer, Davide, et al.. (2017). The neuropathological basis to the functional role of microglia/macrophages in gliomas. Neurological Sciences. 38(9). 1571–1577. 23 indexed citations

10.

Annovazzi, Laura, et al.. (2015). The origin of circumscribed necroses and perinecrotic niches in glioblastoma multiforme: An additional. 3 indexed citations

11.

Annovazzi, Laura, Valentina Caldera, Marta Mellai, et al.. (2015). The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment. International Journal of Oncology. 46(6). 2299–2308. 39 indexed citations

12.

Battaglia, Luigi, Marina Gallarate, Elena Peira, et al.. (2014). Solid Lipid Nanoparticles for Potential Doxorubicin Delivery in Glioblastoma Treatment: Preliminary In Vitro Studies. Journal of Pharmaceutical Sciences. 103(7). 2157–2165. 75 indexed citations

13.

Mellai, Marta, Valentina Caldera, Laura Annovazzi, et al.. (2013). Promoter Hypermethylation of theEMP3Gene in a Series of 229 Human Gliomas. BioMed Research International. 2013. 1–11. 15 indexed citations

14.

Riganti, Chiara, Iris C. Salaroglio, Valentina Caldera, et al.. (2013). Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway. Neuro-Oncology. 15(11). 1502–1517. 64 indexed citations

15.

Riganti, Chiara, Iris C. Salaroglio, Valentina Caldera, et al.. (2013). Temozolomide down-regulates P-glycoprotein in human blood–brain barrier cells by disrupting Wnt3 signaling. Cellular and Molecular Life Sciences. 71(3). 499–516. 47 indexed citations

16.

Schiffer, Davide, et al.. (2012). Glioblastoma cancer stem cells: Basis for a functional hypothesis. 2(3). 122–131. 12 indexed citations

17.

Giordano, Mara, Marta Mellai, M.G. Limongelli, et al.. (2006). A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes and Immunity. 7(7). 606–608. 24 indexed citations

18.

Mellai, Marta, Mara Giordano, Sandra D’Alfonso, et al.. (2003). Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Human Immunology. 64(2). 274–284. 29 indexed citations

19.

D’Alfonso, Sandra, Marta Mellai, Mara Giordano, et al.. (2002). Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene and study of their association with multiple sclerosis. Journal of Neuroimmunology. 126(1-2). 196–204. 11 indexed citations

20.

D’Alfonso, Sandra, Mara Giordano, Marta Mellai, et al.. (2002). Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes and Immunity. 3(8). 454–463. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact